Project Grant K01DK140613

Award Date 7/15/25
Completion Date 5/31/30
Dollars Obligated $159K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
This Project Grant award of $583,732 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research on molecular prediction, disease progression, and type 2 diabetes (T2D) phenotypes in South Asians. The key objectives are to: Investigate genetic associations with T2D and prediabetes phenotypes, develop polygenic risk scores, and explore associations between genetic...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund the development of a culturally adapted digital health application for older Hispanic patients with type 2 diabetes. The $376,208 award, granted on September 20, 2024, will be used to transform a previously developed prototype intervention into a modernized, user-friendly mobile app. The...
This Project Grant award, funded by the Department of Health and Human Services' National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310), provides $324,883 to support a pilot trial of an intervention to improve initial type 2 diabetes self-management among younger adults with children. The project aims to develop an effective behavior change intervention that can influence long-term diabetes-related health outcomes during the critical first year following...
This $512,812 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports a pilot randomized trial to test the feasibility and preliminary efficacy of the T1CARE intervention. T1CARE aims to address social determinants of health for young adults with type 1 diabetes through comprehensive assessment, responsiveness, and engagement. The study will partner with a community-based...
This federal Project Grant award from the National Institute of Nursing Research (NINR) under CFDA 93.361 (Nursing Research) aims to study the impact of the REDDCAT2 intervention on readmission risk and health outcomes for patients with type 2 diabetes. The $2,271,519 award to the University of Massachusetts Medical School will fund the development and implementation of a comprehensive screening tool (REDD-CAT) and patient navigation protocol to identify and address social determinants of health...
This $1,506,686 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research supports a pragmatic, clinic-based trial of a mindfulness-based intervention for mood concerns in youth with type 1 diabetes. The primary goal is to conduct a full-scale efficacy trial of the "BREATHE-T1D" intervention, as compared to a health education control condition, across two...
This $170,100 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will fund the development and piloting of "FUERTE: Federally Qualified Health Centers Engaging Hispanic Men at Risk of Diabetes." The goal is to create a multi-component implementation strategy to increase referrals and engagement of Hispanic men in the Diabetes Prevention Program...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) provides $211,590 to Carnegie Mellon University to conduct research on the time-varying psychosocial influences of blood glucose among adults with type 1 diabetes. The 18-month project will combine ecological momentary assessments and continuous glucose monitoring data from 50 participants to investigate how mood, stress, and social interactions impact blood glucose outcomes in...
This Project Grant award of $731,071 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research to address barriers to equitable, guideline-recommended diabetes care in the United States. The research, led by The Johns Hopkins University, will leverage large real-world datasets and survey physicians to: 1) describe disparities in diabetes care and outcomes across individual,...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $167,864 to The General Hospital Corporation, doing business as Massachusetts General Hospital, to conduct a mixed-methods study on adapting and developing a diabetes self-management education and support (DSMES) intervention for people with type 2 diabetes experiencing food insecurity. The key objectives of the...

This federal Project Grant award of $158,943.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support a community-engaged pilot intervention to address comorbid type 2 diabetes (T2D) and depression among South Asian populations in New York City.

The primary goals are to: 1) examine factors associated with distress, poor mental health, and comorbid T2D and depression; 2) adapt an existing community health worker (CHW)-led T2D intervention to include mental health and digital health components using a trauma-informed care approach; and 3) evaluate the feasibility and acceptability of the adapted CHW-led intervention to support participants with T2D who are at risk for depression. The pilot intervention will leverage digital tools like text message discussion groups and wearable fitness trackers to reinforce health messages and monitor participant progress. The award will be administered by New York University, which has extensive expertise in biomedical research, clinical studies, and translational medicine.

Generated 8/5/25, 5:14 AM